By Class Jul 25, 2018

Class

Brand Name

Generic/Common Name

Status

Manufacturer

Nucleoside reverse
transcriptase inhibitor; NRTI

Epivir-HBV

lamivudine, 3TC

Approved

GlaxoSmithKline

Hepsera

adefovir, ADV

Approved

Gilead Sciences

Baraclude

entecavir, ETV

Approved

Bristol-Myers Squibb

Vemlidy

tenofovir alafenamide, TAF

Approved

Gilead Sciences

Viread

tenofovir disoproxil fumarate, TDF

Approved

Gilead Sciences

Interferon-alfa

Intron A

interferon alfa-2b

Approved

Merck